The Impact of Liver Disease Aetiology and the Stages of Hepatic Fibrosis on the Performance of Non-Invasive Fibrosis Biomarkers: An International Study of 2411 Cases

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2011.04861.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter to the Editors: Cystic Fibrosis Liver Disease in Adults: Limits of Non Invasive Tests of Fibrosis

Hepatology
MedicineHepatology
2018English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Non-Invasive Markers for Hepatic Fibrosis

BMC Gastroenterology
MedicineGastroenterology
2011English

P16 Non-Invasive Evaluation of Fibrosis in Paediatric Chronic Liver Disease

Gut
Gastroenterology
2011English

Progress in Non-Invasive Detection of Liver Fibrosis

Cancer Biology and Medicine
Cancer ResearchOncology
2018English

Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis

International Journal of Hepatology
Hepatology
2012English

Non-Heavy Drinking and Worsening of Non-Invasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study

Hepatology
MedicineHepatology
2018English

Prevalence of Liver Fibrosis and Risk Factors in a General Population Using Non-Invasive Biomarkers (FibroTest)

BMC Gastroenterology
MedicineGastroenterology
2010English

The Association Between a Non-Invasive Hepatic Fibrosis Score and Urolithiasis Among Non-Alcoholic Fatty Liver Disease (NAFLD) Patients in China: A Cross-Sectional Study

BMJ Open
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy